FDA Recall of BD Kiestra ReadA Devices
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has announced a recall of BD Kiestra ReadA devices due to potential delays in plate retrieval after system reboots, affecting 82 units distributed in several U.S. states.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 14, 2026 and geographically references United States (KS, MD, MN, NJ, TX, VA). Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Devices.
FDA Recall of BD Kiestra ReadA Devices
What Happened
The recall was initiated because in certain situations following a system reboot, one or more modules may become unreachable via the remote connectivity interface, potentially causing intermittent delays in plate retrieval from the incubator. This issue does not affect test results, performance of the assay, or sample integrity.
Which Products Are Affected
The affected product is the BD Kiestra ReadA, with Catalog No.: 446948. It includes UDI-DI: 00382904469481 and affects all serial numbers. A total of 82 units are involved, with 7 units in the U.S. and 65 units outside the U.S. The distribution in the U.S. includes the states of KS, MD, MN, NJ, TX, and VA, along with international distribution to countries such as Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, Italy, Kuwait, Mexico, Morocco, Netherlands, Norway, Saudi Arabia, Spain, Sweden, Switzerland, Taiwan, and the United Kingdom. The recall number is Z-1658-2026.
What You Should Do
Consumers who have the affected BD Kiestra ReadA devices should contact the recalling firm, BD KIESTRA LAB AUTOMATION, as the recall was initiated via letter. For returns or refunds, reach out to the firm at their address: Marconilaan 6, Drachten, Netherlands.
Why This Matters
This recall highlights potential operational disruptions in laboratory settings due to connectivity issues, which could delay processes but pose no risk to health or sample integrity.
Source
Attribution: FDA. Recall information can be found via the FDA's database using recall number Z-1658-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,636 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to April 14, 2026.
Frequently Asked Questions
Common questions about this FDA recall.